Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease (Molecular Neurodegeneration, (2022), 17, 1, (27), 10.1186/s13024-022-00521-3)

Pieter Jelle Visser; Lianne M. Reus; Johan Gobom; Iris Jansen; Ellen Dicks; Sven J. van der Lee; Magda Tsolaki; Frans R.J. Verhey; Julius Popp; Pablo Martinez-Lage; Rik Vandenberghe; Alberto Lleó; José Luís Molinuevo; Sebastiaan Engelborghs; Yvonne Freund-Levi; Lutz Froelich; Kristel Sleegers; Valerija Dobricic; Simon Lovestone; Johannes Streffer; Stephanie J.B. Vos; Isabelle Bos; August B. Smit; Philip Scheltens; Charlotte E. Teunissen; Lars Bertram; Betty M. Tijms; August B. Smit; Kaj Blennow; Lars Bertram; Henrik Zetterberg; Betty M. Tijms

ArticleOPEN ACCESS

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease (Molecular Neurodegeneration, (2022), 17, 1, (27), 10.1186/s13024-022-00521-3)

Visser P
Reus L
Gobom J
et al.

Molecular Neurodegeneration

DOI: 10.1186/s13024-022-00540-0

1Citations

6Readers

Abstract

The original article [1] contained an error in co-author, Lars Bertram’s affiliation which has since been corrected.

Cite

CITATION STYLE

APA

Visser, P. J., Reus, L. M., Gobom, J., Jansen, I., Dicks, E., van der Lee, S. J., … Tijms, B. M. (2022, December 1). Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease (Molecular Neurodegeneration, (2022), 17, 1, (27), 10.1186/s13024-022-00521-3). Molecular Neurodegeneration. BioMed Central Ltd. https://doi.org/10.1186/s13024-022-00540-0

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease (Molecular Neurodegeneration, (2022), 17, 1, (27), 10.1186/s13024-022-00521-3)

Abstract

Cite

Register to see more suggestions